OSE Immunotherapeutics S.A.
OSE.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | €17 | €19 | €26 | €34 |
| Short-Term Investments | €0 | €0 | €0 | €0 |
| Receivables | €4 | €2 | €8 | €2 |
| Inventory | €0 | €0 | €0 | €0 |
| Other Curr. Assets | €49 | €10 | €3 | €9 |
| Total Curr. Assets | €70 | €30 | €37 | €44 |
| Property Plant & Equip (Net) | €3 | €4 | €5 | €5 |
| Goodwill | €0 | €0 | €0 | €0 |
| Intangibles | €44 | €46 | €49 | €51 |
| Long-Term Investments | €6 | €1 | €1 | €1 |
| Tax Assets | €0 | €0 | €0 | €0 |
| Other NC Assets | €0 | €0 | €0 | €0 |
| Total NC Assets | €54 | €52 | €54 | €57 |
| Other Assets | €0 | €0 | €0 | €0 |
| Total Assets | €124 | €82 | €92 | €102 |
| Liabilities | – | – | – | – |
| Payables | €3 | €6 | €5 | €3 |
| Short-Term Debt | €8 | €7 | €4 | €2 |
| Tax Payable | €0 | €0 | €0 | €0 |
| Deferred Revenue | €0 | €0 | €1 | €1 |
| Other Curr. Liab. | €4 | €5 | €7 | €10 |
| Total Curr. Liab. | €20 | €19 | €16 | €17 |
| LT Debt | €38 | €39 | €41 | €35 |
| Deferred Rev, NC | €0 | €0 | €4 | €4 |
| Deferred Tax Liab, NC | €1 | €1 | €2 | €2 |
| Other NC Liab. | €0 | €0 | €1 | €1 |
| Total NC Liab. | €40 | €40 | €43 | €37 |
| Other Liabilities | €0 | €0 | €0 | €0 |
| Cap. Leases | €3 | €4 | €4 | €5 |
| Total Liabilities | €60 | €59 | €59 | €54 |
| Equity | – | – | – | – |
| Pref Stock | €0 | €0 | €0 | €0 |
| Common Stock | €4 | €4 | €4 | €4 |
| Retained Earnings | -€18 | -€23 | -€36 | -€21 |
| AOCI | -€0 | -€0 | -€0 | -€0 |
| Other Equity | €77 | €42 | €65 | €65 |
| Total Equity | €64 | €23 | €33 | €48 |
| Supplemental Information | – | – | – | – |
| Minority Interest | €0 | €0 | €0 | €0 |
| Total Liab. & Tot. Equity | €124 | €82 | €92 | €102 |
| Net Debt | €30 | €27 | €19 | €4 |